- Report
- June 2023
- 132 Pages
Global
From €903EUR$950USD£759GBP
- Report
- June 2023
- 132 Pages
Global
From €903EUR$950USD£759GBP
- Report
- September 2024
- 300 Pages
Global
From €2524EUR$2,655USD£2,120GBP
- Book
- January 2018
- 392 Pages
- Book
- April 2010
- 322 Pages
- Book
- October 2022
Latin America
- Book
- October 2023
North America

The Obesity market is a therapeutic area that focuses on the treatment of obesity and related conditions. It includes a range of treatments, from lifestyle changes such as diet and exercise to medications and surgical interventions. The goal of these treatments is to reduce the risk of obesity-related health complications, such as type 2 diabetes, heart disease, and stroke.
The market is driven by a growing awareness of the health risks associated with obesity, as well as the increasing prevalence of the condition. Additionally, advances in medical technology have enabled more effective treatments for obesity, such as bariatric surgery.
Several companies are active in the Obesity market, including Novo Nordisk, Orexigen Therapeutics, Arena Pharmaceuticals, and Vivus. These companies are focused on developing treatments for obesity, ranging from lifestyle interventions to medications and surgical interventions. Show Less Read more